ArticleAmerican journal of clinical dermatology2026

Real-World Treatment with Lebrikizumab or Tralokinumab for Atopic Dermatitis: A 60-Week Retrospective Comparative Study.

Teppei Hagino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.